Legal Cocaine, Amanita Pee Method, Vape Bong & Drug Cartels – The Cannadelics Sunday Edition

Welcome to The Cannadelics Sunday Edition, Cannadelics’ weekly newsletter, sent every Sunday morning 11am est with the main stories of the week. This week we look into some unusual drug activities such as legal Cocaine, Amanita pee method, vape bong, drug cartels, Amanita HHC gummies, Cannabis chocolate, DEA & FDA, hemp in Argentina and more.

Don’t forget to check the article on the Amanita Pee Method as while it is not advised, it’s alot of fun to read about… Also see why there is legal Cocaine is Canada, even they didn’t really planned that to happen… Last, the Vape Bong is a new device. What is it and what makes it so special?

In our deals section, you could find rare opportunities on Amanita gummies, Knockout THC gummies, THCA flower and high-potency power 9 gummies. If you happen to like gummies, we have a great newsletter for you!

As always, beside the best stories of the week, our subscribers enjoy exclusive discounts on popular cannabis and psychedelic products. Take a look at our Deal Of The Day offers and subscribe today to our newsletter, or use the sign-in form below:


 Keep yourself updated with the latest Cannabis & Psychedelic stories, such as legal Cocaine, Amanita pee method, vape bong and more: 
Subscribe to our newsletter


The Cannadelics Sunday Edition (3/5/2023) – CA Legal Cocaine, Amanita Pee Method, Vape Bong & Drug Cartels and more

Hi,

Welcome to the Cannadelics Sunday edition, going out every Sunday with the top stories from the cannabis and psychedelics industries. This week we have a mixed bag of stories as well as a few deals from our deal-of-the-day segments.

Thanks for stopping by!


DEAL OF THE DAY

Save Big On Amanita Gummies
(With Cannadelics coupon code)

Save Big On Amanita Gummies

Want to try the new legal psychedelic gummies, made from Amanita Muscaria mushrooms? Take advantage of our ‘Deal of the day’ offers and get it for $2.4/gummy, using the cannadelics coupon code. 

That’s only $24 for a 10-pack of 375 gummies, a great deal for this trending product! 

If you’re curious to try them out, CLICK HERE and use the “cannadelics” coupon code to save 20% on your order. 

Click here to save on Amanita Gummies

(With Cannadelics coupon code)


THE WEEK IN REVIEW:

This week we have some exciting news, starting with a story about Canada selling legal cocaine, Amanita pee method, Psychedelic products at this year’s High Times Hemp Cup, DEA clarification on cannabinoid laws, Vape bong, Drug cartels and much more!


legal cocaine:

Stepping It Up: Canada Approved Two Companies to Sell Cocaine

Canada approved legal cocaine sales for two companies in BC
Canada approved legal cocaine sales for two companies in BC

Legal Cocaine???
One of the few substances we consider when we think of drug reform is cocaine. Yet in Canada, that’s exactly what is going on, as Health Canada just announced that they have made allowances for two companies to legally sell cocaine. Yes, Cocaine, the famous white central nervous system (CNS) stimulant people use for sun. This comes after British Columbia already decriminalized hard drugs within the province, as a way of dealing with the growing opioid use, and overdose rate.

Continue reading »


Amanita Mushroom Products at 2023 High Times Hemp Cup

Amanita Mushroom Products at 2023 High Times Hemp Cup Kits. But no legal cocaine...
Amanita Hemp Cup products
(Screenshot from hthempcup)

The 2023 High Times Hemp Cup is introducing a new product to the competition – Amanita Hemp Cup products that contain muscimol from Amanita muscaria mushrooms, combined with popular cannabinoids. The Amanita Hemp Cup products include gummies and pre-rolled joints containing muscimol combined with HHC, Delta 8 THC, and CBD.

Continue reading »


Special deal on Amanita Muscaria gummies: only $2.4/gummy

The Vape Bong: Best of Both Worlds

Both bongs and vapes have become staple items in the world of cannabis. Both promote a somewhat cleaner way to consume cannabis than your average blunt or bowl out of a pipe, so it makes sense to combine the two into one super-product! The vape bong represents the best of both worlds, with most vape companies offering a bong attachment as an aftermarket product. Here’s more on how it works.

Continue reading »


Cannabis Chocolate: Does it Taste Like Weed?

cannabis chocolate
Cannabis Chocolate: Does it Taste Like Weed?

Although many people love both cannabis and chocolate, the flavor often leaves something to be desired, if they’re not prepared a certain way. the taste of infused treats can depend on various factors, including the quality of the product, the type of cannabis used, and the manufacturing process. In this article, we will explore these factors make for the best cannabis chocolate.

Continue reading »


DEAL OF THE DAY

Save big on high-THCA flower

Save big on high-THCA flower
THCA Flower Bundle

Introducing an exclusive high-THCA flower bundle – a very limited edition discounted bundle sampler featuring some of the freshest flowers you can buy online . 

This bundle includes 8 eighths of the strains listed below:

  • 3.5g of Afghan THCa Hemp Flower
  • 3.5g of Miracle Alien Cookies THCa Hemp Flower
  • 3.5g of Grand Daddy Purple THCa Hemp Flower
  • 3.5g of Death Star THCa Hemp Flower
  • 3.5g of Hippie Crippler THCa Hemp Flower
  • 3.5g of Gorila Glue Pheno 1 THCa Hemp Flower
  • 3.5g of Green Crack THCa Hemp Flower
  • 3.5g of Blueberry Pheno 1 THCa Hemp Flower

Act fast to get your hands on this exclusive bundle before it’s gone!

Save big on high-THCA flower


Additional Reading:

A few more articles for your reading pleasure, such as legal cocaine in Canada, Amanita pee method, Cannabinoid laws by the DEA, Vape bong, Drug cartels and more!

DEA & FDA: The Confusion Over Legal Drugs VS Legal Products

Does DEA or FDA determine legal products? What about legal cocaine?
DEA & FDA: The Confusion Over Legal Drugs VS Legal Products

It’s been an ongoing battle, but the DEA and FDA have released statement to clarify their stance on various cannabinoids. Are hemp-derived cannabinoids that are completely or partially synthetic, legal? Are the cannabinoids that show up in nature, but are only used for production as synthetics, legal? And what about the products that are made from these compounds? Are they legal? Short answer, no. But click the link to learn more.

Continue reading »


The Amanita Pee Method: Not Advised, But Fun to Read About

Would you drink amanita reindeer pee to get high?
Would you drink amanita reindeer pee to get high?

The amanita pee method is one of the older ways to get high off amanita mushrooms. Luckily, you don’t need to drink any pee just to have an amanita experience. Even back in the same general time period, many Siberians did what you can do today: boil the mushrooms to make a tea. However, the ancient pee method is quite interesting to learn about.

Continue reading »


Clearance sale: 50% off THCO carts, disposables, gummies, tinctures and dabs

New Argentina Hemp Law Expected to Widen Domestic and Export Markets

New Argentina hemp law in place, Illegal Synthetics. What about legal Cocaine?
New Argentina Hemp Law Expected to Widen Domestic and Export Markets

With the help of activist groups like Mama Cultiva, Argentia forced its way into the medical cannabis market. Now, Argentina making even bigger moves by opening the doors for increased hemp production for both domestic and export markets. The announcement for the implementation of the Regulatory Agency for the Hemp and Medical Cannabis Industry (ARICCAME), came out on January 25th, with its first working group to start immediately.

Continue reading »


What is a Drug Cartel?

What is a Drug Cartel?

In the world of illegal substances, drug cartels are the kingpins. If you’ve ever heard of Pablo Escobar and his Medellin Cartel in Colombia, then you’ll have heard of these organizations. But that was then and this is now. Who are the current drug cartels to look out for? But not only that, what actually are they? We’re going to be explaining how drug cartels work, how they thrive and how they do or don’t get caught.

Continue reading »


DEAL OF THE DAY

25% Off The Knockout Blend Gummies 

Have you experienced the new Knockout Blend gummies, a high-potency gummy product that belongs to the next generation? 

Crafted from a perfect combination of three potent cannabinoids – THC-PHHC-P, and THC-H, the Knockout Blend gummies provide an efficient means of delivering the therapeutic and recreational benefits of cannabis to your body. 

The convenience, precision, and subtlety of consuming cannabis via high-potency gummies have made them a popular option among cannabis enthusiasts. But with its exceptional blend of the three super-potent cannabinoids, the Knockout Blend gummies take this experience to an entirely new level.

TIP: save an extra 25% discount with Delta25 coupon code!

Click here to buy the Knockout Gummies

(With Delta25 coupon code)

NEW PRODUCTS:

POWER 9 BLEND GUMMIES

POWER 9 BLEND GUMMIES

If you’re looking for an incredibly potent gummy experience, the Power 9 Blend gummies are just what you need. Each gummy contains 40mg of the exclusive Power 9 Blend formula that blends top-quality live resin Delta 9 THC, THC-JD, and HHC-P distillates with THC-B, Delta 8, HHC, and other ingredients to create a powerful, full-body effect.  

The Strawberry Kiwi flavored Power 9 Blend gummies are taking the world by storm and gaining immense popularity due to the extraordinary buzz they provide. However, we urge users to exercise caution when dosing, as they are incredibly strong… So, be careful when dosing to ensure a safe and enjoyable experience. 

TIP: Get it for an extra 25% discount using the Delta25 coupon code!
posables, dabs, tinctures, and edibles at prices never seen before.

Click here to buy the Power 9 gummies

(With Delta25 coupon code)

Keep Yourself Informed

For all the latest from Psychedelics and Cannabis, plus some exclusive deals on premium products, subscribe to our weekly newsletter.

Get our weekly updates


News from the Week:


*** Ecuador Expanded Hemp Industry to Include More Industrial Uses

*** What’s The Deal with Shoddy Vape Carts Lately?

*** Brazil: Cannabis Startup Capital of the World?

*** 2023 Farm Bill Under Construction: What to Expect For Hemp

*** Does A Medical Setting Affect Psychedelic Treatment?

*** How Legal Cannabis Affects Pharmaceutical Sales


Legal cocaine, Amanita pee method, Drug cartels – Conclusion

We hope you enjoyed this week’s review. We work hard to find and verify the best products, so we may include affiliate links to support the maintenance and development of this site. 

Best, 
The Cannadelics team 

*** Disclaimer: As the legality of cannabinoids and psychedelics changes between state to state, you should always check with your local authorities first.

The post Legal Cocaine, Amanita Pee Method, Vape Bong & Drug Cartels – The Cannadelics Sunday Edition appeared first on Cannadelics.

Illegal Synthetics, Amanita Hemp Cup Products, Cannabis Music Banned – The Cannadelics Sunday Edition

Welcome to our weekly newsletter, The Cannadelics Sunday Edition, emailed to our subscribers every Sunday morning 11am est, with the main items of the week. This week we look into Illegal Synthetics, new Amanita mushroom Hemp Cup products, Cannabis music and media getting banned, Cannabis tourism in Uruguay, Trainspotting, Argentina hemp laws, Amanita beginners guide and types of hangovers and more.

As always, In addition the weekly digest, the newsletter comes with few of our Deal Of The Day offers. As always, the best Cannabis and Psychedelic products are reserved for our readers, so subscribe today or use the sign-in form below:


 Keep yourself updated with the latest Cannabis & Psychedelic stories, such as Illegal Synthetics, Amanita hemp cup products and more: 
Subscribe to our newsletter


The Cannadelics Sunday Edition (2/26/2023) – Illegal Synthetics, Amanita Hemp Cup Products, Cannabis Music Banned and more

Hi,

Welcome to the Cannadelics Sunday edition, going out every Sunday with the top stories from the cannabis and psychedelics industries. This week we have a mixed bag of stories as well as a few deals from our deal-of-the-day segments.

Thanks for stopping by!


DEAL OF THE DAY

Amanita HHC Gummies

Amanita HHC Gummies

Be a part of history by trying out the latest Cannadelic additions to the 2023 High Times Hemp Cup – the new Amanita HHC gummies and Amanita HHC joints, both featuring psychedelic mushrooms. High Times has never before included these types of products in their hemp cup, making this a groundbreaking event. 

Of particular interest are the more potent offerings, such as the Amanita HHC Amanita gummies and the Amanita D8 joints. The HHC gummies stand out for two reasons: they feature HHC (hexahydrocannabinol), a simplified version of THC, and they’re a rare combination of gummy and chocolate. 

If you’re curious to try them out, CLICK HERE and use the “cannadelics” coupon code to save 20% on your order. 

Click here to buy Amanita HHC gummies

(With Cannadelics coupon code)


THE WEEK IN REVIEW:

This week we have a pretty even mix of both cannabis and psychedelics news. Among this stories, we have one explaining the DEA’s clarification on Illegal Synthetics. We’re also covering a recent ban on cannabis themed music and media in the Dominican Republic, a federal judge’s rule on cannabis and guns in Oklahoma, new Amanita mushroom products in hemp cup and so much more!


Illegal Synthetics:

Illegal Synthetics: DEA Reiterates That Synthetic Cannabinoids Are Illegal

Illegal Synthetics: DEA says synthetic cannabinoids are illegal
Illegal Synthetics: DEA Reiterates That Synthetic Cannabinoids Are Illegal

This debate has been raging on for years- are synthetic “hemp-derived” cannabinoids federally legal or not? Some claim vehemently that they are, while others remain skeptical. However, a recent statement from the FDA offers us some clarity, claiming that synthetic cannabinoids are in fact, illegal, even if they are hemp-derived. 

Continue reading »


Amanita Mushroom Products at 2023 High Times Hemp Cup Kits

Amanita Mushroom Products at 2023 High Times Hemp Cup Kits
Amanita Hemp Cup products
(Screenshot from https://hthempcup.com)

The 2023 High Times Hemp Cup is introducing a new product to the competition – Amanita Hemp Cup products that contain muscimol from Amanita muscaria mushrooms, combined with popular cannabinoids. The Amanita Hemp Cup products include gummies and pre-rolled joints containing muscimol combined with HHC, Delta 8 THC, and CBD.

Continue reading »


Special deal on Amanita Muscaria gummies: only $2.4/gummy

Dominican Republic Banned Cannabis Themed Music & Media

Dominican Republic Banned Cannabis Themed Music & Media
Dominican Republic cannabis

While most of the cannabis-related news stories these days show different regions relaxing regulations against the plant, some places, are heading steadfast in the opposite direction. Take the Dominican Republic, for instance. Not only are they not even considering any type of cannabis legislation, they actually took things a step further and banned cannabis themed music and media.

Continue reading »


Uruguay Working Toward Cannabis Tourist Industry to Fight Black Market

Global cannabis tourism
Global cannabis tourism

Although it often flies under the radar in many discussions on the subject, Uruguay is the world’s oldest, legal recreational cannabis market. If we follow what happens there, it can give us a good indication of what may transpire in other legal markets throughout the world. Currently, Uruguay is working on bolstering the cannabis tourism industry in order to thwart the still-thriving black market. 

Continue reading »


DEAL OF THE DAY

Save big on high-THCA flower

THCA Flower Bundle

Introducing an exclusive high-THCA flower bundle – a very limited edition discounted bundle sampler featuring some of the freshest flowers you can buy online . 

This bundle includes 8 eighths of the strains listed below:

  • 3.5g of Afghan THCa Hemp Flower
  • 3.5g of Miracle Alien Cookies THCa Hemp Flower
  • 3.5g of Grand Daddy Purple THCa Hemp Flower
  • 3.5g of Death Star THCa Hemp Flower
  • 3.5g of Hippie Crippler THCa Hemp Flower
  • 3.5g of Gorila Glue Pheno 1 THCa Hemp Flower
  • 3.5g of Green Crack THCa Hemp Flower
  • 3.5g of Blueberry Pheno 1 THCa Hemp Flower

Act fast to get your hands on this exclusive bundle before it’s gone!

Save big on high-THCA flower


Additional Reading:

A few more articles for your reading pleasure, such as the 2023 farm-bill, medical cannabis, salvia, Delta 9 vs Delta 8 etc.

Trainspotting: The Truth about Scotland and Heroin

trainspotting heroin / Illegal Synthetics
Trainspotting: The Truth about Scotland and Heroin

When Trainspotting, written by the Irvin Welsh and directed by the equally wonderful Danny Boyle, was released in 1996, people knew that they had a nuanced and well-thought-out film about heroin addiction on their hands. Trainspotting forced its way into many viewer’s ‘best films of all time’ list and rightfully so. But why did a movie about a group of Scottish friends dealing with drug and life issues become such a cult classic? Perhaps, simply, because told the sad truth about opioid addiction.

Continue reading »


Amanita Muscaria Beginner’s Guide: Everything You Need to Know

Amanita Muscaria Beginner's Guide
Amanita Muscaria Beginner’s Guide

Amanita muscaria, also known as Fly Agaric, is a fascinating old world mushroom that has recently grown in popularity due to the fact that it is very loosely regulated compared to other types of psychedelic mushrooms. If you’re a beginner looking to try Amanita Muscaria, it’s crucial to take the necessary precautions before consuming it, as all good things comes with responsibility and any drug can be problematic when used incorrectly.

Continue reading »


Clearance sale: 50% off THCO carts, disposables, gummies, tinctures and dabs

New Argentina Hemp Law Expected to Widen Domestic and Export Markets

New Argentina hemp law in place, Illegal Synthetics
New Argentina Hemp Law Expected to Widen Domestic and Export Markets

With the help of activist groups like Mama Cultiva, Argentia forced its way into the medical cannabis market. Now, Argentina making even bigger moves by opening the doors for increased hemp production for both domestic and export markets. The announcement for the implementation of the Regulatory Agency for the Hemp and Medical Cannabis Industry (ARICCAME), came out on January 25th, with its first working group to start immediately.

Continue reading »


Why All Types of Alcohol Cause the SAME Hangover?

Alcohol hangover, Illegal Synthetics
Alcohol hangover

Some people swear that certain alcohols produce different types of hangovers, similar to the way the produce different drunk effects. While that may be true for certain people, it’s more of a matter of personal body chemistry rather than the alcohol itself. As a matter of fact, scientific literature indicates that all alcohols actually result in the exact same hangover. 

Continue reading »


DEAL OF THE DAY

Medical Cannabis Card Online

At MMJ.com, you can obtain your medical marijuana card online from a state-certified medical marijuana doctor. Thousands of patients have already received their new MMJ card, renewal, or 12-month prescription – and now it’s your turn! 
Rest assured that you’ll receive the doctor’s certification or they will give you your money back with as it is 100% money-back guarantee

Don’t wait any longer – get started now and experience the convenience of obtaining your medical marijuana card from the comfort of your own home.

Click here to get your Medical Card


NEW PRODUCTS:

Amanita HHC Gummies & Amanita Delta 8 Joints

Amanita Delta 8 Joints
Amanita HHC Gummies & Amanita Delta 8 Joints

Get ready to experience the latest addition to the 2023 High Times Hemp Cup – the Amanita Mushroom products featuring muscimol from Amanita muscaria mushrooms, combined with popular cannabinoids. These products are sure to give you a unique and exciting experience, producing psychoactive effects that will transport you to another world. 
Among the offerings are the Amanita HHC gummies and Amanita D8 joints, both featuring rare and potent combinations. 
posables, dabs, tinctures, and edibles at prices never seen before.

Buy Amanita HHC gummies & Amanita Delta 8 joints


Keep Yourself Informed

All the latest from Psychedelics and Cannabis - Illegal Synthetics
All the latest from Psychedelics and Cannabis

For all the latest from Psychedelics and Cannabis, follow our Telegram Channel.

 Get our daily updates


News from the Week:

*** Coco Puffs – What’s the Deal with Mixing Cannabis and Cocaine?

*** What’s The Deal with Shoddy Vape Carts Lately?

*** Worse Than Fentanyl? New Opioid Isotonitazene Deepens Opioid Crisis

*** 2023 Farm Bill Under Construction: What to Expect For Hemp

*** Does A Medical Setting Affect Psychedelic Treatment?

*** How Legal Cannabis Affects Pharmaceutical Sales


llegal Synthetics, Amanita Hemp Cup Products, Cannabis Music Banned – Conclusion

We hope you enjoyed this week’s review. We work hard to find and verify the best products, so we may include affiliate links to support the maintenance and development of this site. 

Best, 
The Cannadelics team 

*** Disclaimer: As the legality of cannabinoids and psychedelics changes between state to state, you should always check with your local authorities first.

The post Illegal Synthetics, Amanita Hemp Cup Products, Cannabis Music Banned – The Cannadelics Sunday Edition appeared first on Cannadelics.

Argentina Launches New Agency To Boost Cannabis Industry

Argentina officially launched a new government agency on Wednesday as part of an effort to bolster the country’s medical marijuana and hemp industry. 

Reuters reports that the agency, known as the Regulatory Agency for the Hemp and Medicinal Cannabis Industry, or ARICCAME, represents “the first working group of a new national agency to regularize and promote the country’s nascent cannabis industry, which ministers hope will create new jobs and exports generating fresh income for the South American nation.” 

“This opens the door for Argentina to start a new path in terms of industrial exports, on the basis of huge global demand,” said Argentina’s economy minister Sergio Massa at an event marking the launch of the new agency.

According to Reuters, “Massa said that the agency would from Thursday begin regularizing programs and coordinating with various provinces and [the] industrial sector, adding Argentina already counted on demand for projects linked to the agro-industrial sector.”

On the official website for ARICCAME, the agency outlines its mission and objectives.

“We are the Agency that regulates the import, export, cultivation, industrial production, manufacture, commercialization and acquisition, by any title, of seeds of the cannabis plant, cannabis and its derivative products for medicinal or industrial purposes,” the website reads, via an English translation. 

The website lists the following “general objectives” for the agency: “Establish through the respective regulations, the regulatory framework for the entire production chain and national marketing and/or export of the Cannabis Sativa L. plant, seeds and derivatives for use in favor of health and industrial hemp; Promote a new agro-industrial productive sector for the commercial manufacture of medicines, phytotherapeutics, food and cosmetics for human use, medicines and food for veterinary use, as well as the different products made possible by industrial hemp; Generate the framework for the adaptation to the regulatory regime, of the cultivation and production of cannabis derivatives for use in existing health, guaranteeing the traceability and quality of the products in order to safeguard the right to health of the users of medical cannabis; Reintroduce hemp in Argentina and all its derivatives: food, construction materials, textile fiber, cellulose and bioplastics with low environmental impact; [and] Promote scientific research and sectoral technological progress, promoting favorable conditions for these existing industries in our country.”

ARICCAME’s specific objectives include: “Establish clear rules that provide legal certainty to the sector and encourage federal participation; Articulate through agreements and conventions with other State entities with intervention in the matter: INASE, SENASA, INTA, INTI, AFIP, INAES, BCRA, UIF, National Universities, etc; Determine the system of licenses and administrative authorizations for the productive chain; Generate quality standards that safeguard the right to health of users and consumers of cannabis/hemp products; [and] Control non-compliance with the regulatory regime.”

Argentine policymakers legalized cannabis oil for medical use in 2017. Three years later, the country legalized home cannabis cultivation for medical marijuana patients. 

The launch of the new agency is part of a border effort by the Argentine government to continue to reform the medical cannabis program, something that the South American country identified as a priority last year

According to Reuters, the newly launched agency will be helmed by Francisco Echarren, who “said the industry could generate thousands of new jobs, as well as create technological developments and new products for export.”

“We have a huge challenge ahead of us,” Echarren said, as quoted by Reuters, “not only getting a new industry on its feet, but giving millions of Argentines access to products that improve quality of life.”

The post Argentina Launches New Agency To Boost Cannabis Industry appeared first on High Times.

Researchers Studying Psychedelic Drug as Treatment for Alzheimer’s Disease

A Toronto-based biotech company is researching a new psychedelic drug as a treatment for Alzheimer’s disease, noting in a recent announcement that it has received approval from regulators in Argentina to commence a Phase ll clinical trial of the company’s novel psychedelic compound, BMND08.

“As we continue to move forward with our efforts in identifying indications where we can provide significant improvement in patients suffering from mental health, we are more than pleased to announce the approval of a Phase II clinical trial for our BMND08 novel drug candidate which may allow us to address a new line of development to attenuate depression and anxiety states in patients with Alzheimer’s-type cognitive impairment,” Alejandro Antalich, CEO of Biomind Labs, said in a statement from the company.

Biomind Labs is a biotech research and development company that is studying novel drugs and innovative nanotech delivery systems for a variety of psychiatric and neurological conditions. Using its technology, the company is developing new pharmaceutical formulations of the main psychedelic molecules, N,N-Dimethyltryptamine, 5-MeO-DMT, and mescaline for the potential treatment of a wide range of therapeutic indications, with a focus on providing patients access to affordable and groundbreaking treatments.

“Since our inception, neurodegenerative diseases were on the list of indications we wanted to tackle. We can now address such indications using a novel approach that uses a fast-acting psychedelic molecule capable of providing relief to certain mood states when Alzheimer’s disease first appears in patients,” said Antalich. “After a thorough analysis on the potential benefit of using a psychedelic molecule to alleviate certain symptoms in Alzheimer’s patients, we concluded that the most suitable candidate from our portfolio was BMND08, an oral formulation of 5-MeO-DMT.”

Nearly Six Million American Seniors Live with Alzheimer’s

Alzheimer’s disease is a progressive neurological disorder that causes brain cells to atrophy and die. Nearly six million people in the United States aged 65 and older live with the disease, according to information from the Mayo Clinic. The disease is the most common cause of dementia, a continuous decline in cognitive function and social skills that affects the ability to function independently. Although medications may temporarily improve or slow the progression of symptoms, there is no cure for Alzheimer’s disease. In advanced stages of the disease, complications from significant loss of brain function such as dehydration, malnutrition or infection result in death.

“Given the significant morbidity rate associated with Alzheimer’s disease such as agitation, apathy, sleep disturbances and anxiety, it became clear to us that novel approaches to treat Alzheimer’s-type cognitive impairment are urgently needed,” Antalich said. “The Phase II clinical trial will test Biomind’s psychiatry intervention-based model, allowing a rapid and feasible merge of fast-acting psychedelic medicines into clinical practices already in existence.”

The research is studying whether BMND08, a drug based on the natural psychedelic compound 5-Methoxy-N,N-dimethyltryptamine (also known as 5-MeO-DMT or simply DMT), is effective as a treatment for the depression and anxiety commonly found among patients with Alzheimer’s disease. The Phase ll clinical trial will be conducted in Argentina, where regulators gave approval for the study in May.

Previous studies have shown that more than 60% of patients with Alzheimer’s disease have also been diagnosed with depression. Treating a patient’s depression may also help treat or delay other symptoms associated with Alzheimer’s disease. An unrelated study showed that the antidepressant called imipramine may be effective in treating cognitive decline in patients with the condition. Although some research has studied cannabis as a possible treatment for the symptoms of Alzheimer’s disease, Biomind’s study is believed to be the first to test a psychedelic like DMT.

“While the current practice guidelines consistently refer to the management of symptoms as central to the treatment of Alzheimer’s disease, the lack of established effective treatments continues to motivate us to generate novel therapeutic solutions,” said Antalich.

The post Researchers Studying Psychedelic Drug as Treatment for Alzheimer’s Disease appeared first on High Times.

Argentine Supreme Court Endorses Medical Cannabis Home Grow

In a case sure to reverberate around the world, the Argentinian Supreme Court has ruled that parents of sick children are allowed to grow their own cannabis to treat their children. This decision, they ruled, is in line with existing Argentine law—namely the decriminalization of cannabis for medical purposes.

As family law and cannabis legitimization intersect, this development is about as significant as a similar 2014 Israeli case. Namely, families of sick children requiring medical cannabis threatened to immigrate to Colorado unless they were given the right to obtain medical cannabis domestically. The government changed the law within a matter of weeks.

That said, it was not a complete victory in Argentina last week for those who pressed their case. The Court also ruled, unanimously, that a special patient registry now in effect, is not unconstitutional. This was an issue raised by Mamás Cannabis Medicinal (Macame) which presented the plaintiff’s cause. The Court reasoned that the state had the right to control and track all cannabis cultivation—including for medical purposes.

The decision in Argentina is, of course, significant domestically. Yet coming as it does as country after country is beginning to implement or at least talk about implementing home grow more generally, the timing is also very important. In this decision, the Argentine Court seems to be following a global trend that is emerging in countries as disparate as those in Latin America and Europe (Malta, Italy, Luxembourg, and Portugal, so far) to Asia (notably Thailand). Home grow for both recreational and medical use is very much a la mode in the international normalization discussion now clearly underway both legally and politically.

Why Is Home Grow Becoming a Global Default First Step Towards Reform?

There are several reasons for this rather sudden emergence of something that looks remarkably like a consensus at an international level around issues related to home cultivation. Namely, when faced with both a crisis in healthcare delivery systems in the aftermath of both global austerity followed by a global pandemic, and the inevitability of recreational reform, governments are apparently getting the message.

It is becoming increasingly obvious in other words that home grow is not a seditious way to undermine a legal market (of either the medical or recreational kind). Indeed, when tracked (either by being registered or permitted or both), home cultivation of cannabis is a very sensible path towards a normalized market. See Canada—although, of course, the system is not perfect.

Generally, and most certainly in countries on the verge of recreational reform like Germany (for example) today, it is the case that the people most affected by any delay in full legalization, of any kind, are patients. There are close to 200,000 criminal cases pending in the German courts alone for low level possession, cultivation, and/or use. This is a massive waste of time and money that the state can easily cut. In fact, case law is again beginning to trend in this direction, even if only for now, on appeal. However, increasingly it is also the case that courts are recognizing that insurers are also forcing legitimate patients to take legal action to obtain coverage. In the meantime, they must source their own, taking risks along the way.

For this reason, the entire role around home grow is likely to change aus Deutschland as it has in other places, albeit here, at this juncture more likely by legislation than legal action as has just occurred in Argentina.

Prosecuting sick people is not a winning look anywhere right now. In fact, making it easier for the chronically ill to more or less treat themselves at a time when healthcare systems are straining to keep up with just “regular” care, just sounds sensible no matter which way one looks at this. Or where. For an extreme example, see Ukraine. But beyond this, every western state is struggling with chronic care provision—including for those conditions normally treated with cannabis.

On top of such realities, of course, such legal and political decisions are coming at a time when states are being forced to look at how enforcement of rules if not laws themselves takes place—and for issues and themes far from just cannabis reform.

Even though the Canadian model has shown that patients are absolutely going to be “competition” to the industry, in that they do not have to rely on a commoditized, bought product, there is another way to look at all of this. Indeed, it is also the case that patient home grow is a way to stimulate the legal, regulated market. Not to mention the broader economy beyond that which will benefit from money diverted from medication purchase.

Growing cannabis is not easy and takes energy. While there will always be recreational hobbyists, most people, including patients, would rather be able to buy cannabis in all its forms the way they buy food, medication, and other legal products.

This in turn creates jobs, revenue, and taxes.

The trick, of course, is to find a middle ground that allows both sides to flourish.

Just as legalization itself is inevitable, so is the right of people to grow their own cannabis, and for whatever use.

It is, after all, beyond all the demonization and stigma, “just” a plant.

The post Argentine Supreme Court Endorses Medical Cannabis Home Grow appeared first on High Times.

Brazil Legalizes Home-Grown Medical Cannabis 

Brazil’s Superior Court has effectively legalized medical cannabis for home-grown use. The decision is likely to set a precedent for similar cases. The Brazilian government has not yet responded to the court’s decision. What Happened The five-judge panel unanimously agreed that Brazil’s patients should have access to home-grown medical cannabis. The three patients on trial […]

The post Brazil Legalizes Home-Grown Medical Cannabis  appeared first on Cannabis News, Lifestyle – Headlines, Videos & Cooking.

Exclusiva – Ministro Kulfas Sobre Ley de Cannabis: ‘Le Va a Dar Mucho Bienestar a la Argentina’

Nota por Javier Hasse y Franca Quarneti publicada originalmente en El Planteo. Más artículos por El Planteo en High Times en Español.

Síguenos en Instagram (@El.Planteo) y Twitter (@ElPlanteo).

En diálogo exclusivo con El Planteo, el ministro de Desarrollo Productivo de la Nación, Matías Kulfas, se refirió a la ley de desarrollo de la industria del cannabis medicinal y cáñamo industrial que fue aprobada el pasado jueves.

“Le va a dar mucho bienestar a la Argentina”, aseguró Kulfas, hablando sobre normativa que se sancionó con 155 votos a favor, 56 en contra y 19 abstenciones en la Cámara de Diputados del Congreso Nacional.

Contenido relacionado: Argentina: Aprueban Ley Cannabis Medicinal y Cáñamo Industrial

Con esta nueva ley, se buscará crear un marco regulatorio para la inversión pública y privada de la naciente industria del cannabis y completar la normativa actual de cannabis medicinal (Ley 27.35o).

Además, se creará una agencia de regulación, la ARICCAME (Agencia Regulatoria del Cáñamo y del Cannabis Medicinal). Esta regulará la importación, exportación, cultivo, producción industrial, fabricación, comercialización y adquisición de semillas, de la planta de cannabis y de sus productos derivados con fines medicinales o industriales.

¿Qué dijo el ministro Matías Kulfas sobre la nueva ley de cannabis?

En conversaciones con Javier Hasse, CEO de El Planteo, Kulfas celebró la sanción de la normativa: “Muy contento, la verdad que fue un esfuerzo muy grande”. 

Contenido relacionado: Corte Suprema de Argentina Trata la Legalidad del Autocultivo de Cannabis en Audiencia Histórica

Entretanto, el ministro de Desarrollo Productivo agradeció el trabajo de todas y todos los que hicieron que la ley fuera posible.

“Primero, reconocer la lucha de muchos años de las organizaciones, de Mama Cultiva, de todos los productores que vienen trabajando justamente para darle visibilidad a este tema”, comenzó.

Y siguió: “A mis compañeras diputadas, Carolina Gaillard y Mara Brawer y a mucha gente que se puso este tema al hombro. A todo el equipo del Ministerio de Desarrollo Productivo que trabajó intensamente para armar el proyecto y sus fundamentos. A Andrés López, un gran investigador de la UBA, que armó ese documento base que nos sirvió muchísimo. Y bueno, a todo el trabajo político y, por supuesto, agradecer a todos los diputados y diputadas, sin distinción de banderas políticas, porque la verdad que logramos una mayoría importante“.

Contenido relacionado: Cannabis Legal y Transición Productiva: PyMES Argentinas Adelantan su Visión del Mercado Potencial

Asimismo, el economista del Frente de Todos subrayó la importancia que tendrá la iniciativa en el sector productivo del país. “Este es un proyecto para Argentina, no es un proyecto para un sector político. Está orientado a la producción nacional, al trabajo argentino y a la industria. Se trata de un proyecto federal que va a tener muchísima representatividad en diferentes provincias”.

“Esperamos que sea el inicio de un nuevo sector industrial que le va a dar mucho bienestar a la Argentina y le va a dar soluciones terapéuticas a la gente que las necesita y también opciones productivas con el cáñamo”, concluyó Matías Kulfas.

The post Exclusiva – Ministro Kulfas Sobre Ley de Cannabis: ‘Le Va a Dar Mucho Bienestar a la Argentina’ appeared first on High Times.

Argentina Makes Medical Cannabis Reform a National Priority

It is not just German lawmakers who are suddenly deciding that cannabis reform should be top of the political agenda this year; in Argentina, an agreement between the ruling party and the opposition will now put at least medical cannabis reform on the docket.

The Chamber of Deputies (which has only met once so far this year) has now agreed to not only meet but to further discuss cannabis reform when they do. The bill on the table will include regulations to create a framework for the development of a medical cannabis and industrial hemp industry.

This is a development that has now been pending since July of last year when, after being proposed by the national government, it was subsequently blocked by the opposition over a lack of agreement on the particulars. 

This, of course, is far from an unusual situation—see the state of federal reform in the U.S. right now for exactly the same reason. 

The Post-COVID Political Cannabis Football

Argentina, in fact, is joining both the U.S. and Germany in prioritizing federal cannabis reform this year, no matter the delays and stutters along the way. Just this week, the German press began reporting that government leaders, including the Minister of Health, were changing their tune on the need to move forward on some kind of recreational cannabis reform by this summer.

Cannabis normalization has actually been cooking slowly in Argentina since 2009, when the Supreme Court decriminalized cannabis for personal use in private. In 2017, at approximately the same time Germany decided to mandate public health insurance coverage of medical cannabis, the Argentine Senate approved the medical use of cannabis oil. In 2020 home cultivation was also approved.

Countries are clearly watching each other right now on progressing the entire reform issue—no matter where they are in the process of cannabis acceptance. For this reason, the proximate announcements in national legislatures now coming from all over the world appear to be a global trend. Legalization, if not normalization, is also highly likely to show up in other countries now coming out of the pandemic where political leaders desperately need to find both development projects with credible prospects of creating jobs, tax revenue, and potentially also have positive environmental impact. 

Cannabis legalization is a popular reform everywhere. Supporting the same gives credibility to a political process that itself is challenged if not deadlocked in partisan fights in multiple countries. Consideration of this issue, as well as passage of legalization legislation, not only gives such leaders credibility but represents something that they might actually be able to accomplish.

The End of the Latin American Drug War

The recent indications by multiple countries in both Central and South America that they are going to cultivate the growth of this industry (or are considering it) is a sea change that cannot be underestimated. The South American hemisphere was the top target of the U.S. from the 1970s until well into this century for a hot war that was never labelled as such but took many casualties.

Indeed, Uruguay, the first country in the world to declare that it would allow recreational reform, was blackmailed by the U.S. banking system for years after 2013 to slow down its internal development of the industry.

These days, that conversation is clearly not taking place, although federal reform (of any sort, let alone of the recreational kind) again seems to be destined to stall in the U.S. Congress.

Argentina certainly seems to be positioning itself on this issue as developments occur in both the U.S. and Germany (for starters). That makes a great deal of sense. Both countries are ideal export markets for a product that Argentina is well developed to deliver as a high value export crop in both hemispheres.

The post Argentina Makes Medical Cannabis Reform a National Priority appeared first on High Times.

Argentina Makes Medical Cannabis Reform a National Priority

It is not just German lawmakers who are suddenly deciding that cannabis reform should be top of the political agenda this year; in Argentina, an agreement between the ruling party and the opposition will now put at least medical cannabis reform on the docket.

The Chamber of Deputies (which has only met once so far this year) has now agreed to not only meet but to further discuss cannabis reform when they do. The bill on the table will include regulations to create a framework for the development of a medical cannabis and industrial hemp industry.

This is a development that has now been pending since July of last year when, after being proposed by the national government, it was subsequently blocked by the opposition over a lack of agreement on the particulars. 

This, of course, is far from an unusual situation—see the state of federal reform in the U.S. right now for exactly the same reason. 

The Post-COVID Political Cannabis Football

Argentina, in fact, is joining both the U.S. and Germany in prioritizing federal cannabis reform this year, no matter the delays and stutters along the way. Just this week, the German press began reporting that government leaders, including the Minister of Health, were changing their tune on the need to move forward on some kind of recreational cannabis reform by this summer.

Cannabis normalization has actually been cooking slowly in Argentina since 2009, when the Supreme Court decriminalized cannabis for personal use in private. In 2017, at approximately the same time Germany decided to mandate public health insurance coverage of medical cannabis, the Argentine Senate approved the medical use of cannabis oil. In 2020 home cultivation was also approved.

Countries are clearly watching each other right now on progressing the entire reform issue—no matter where they are in the process of cannabis acceptance. For this reason, the proximate announcements in national legislatures now coming from all over the world appear to be a global trend. Legalization, if not normalization, is also highly likely to show up in other countries now coming out of the pandemic where political leaders desperately need to find both development projects with credible prospects of creating jobs, tax revenue, and potentially also have positive environmental impact. 

Cannabis legalization is a popular reform everywhere. Supporting the same gives credibility to a political process that itself is challenged if not deadlocked in partisan fights in multiple countries. Consideration of this issue, as well as passage of legalization legislation, not only gives such leaders credibility but represents something that they might actually be able to accomplish.

The End of the Latin American Drug War

The recent indications by multiple countries in both Central and South America that they are going to cultivate the growth of this industry (or are considering it) is a sea change that cannot be underestimated. The South American hemisphere was the top target of the U.S. from the 1970s until well into this century for a hot war that was never labelled as such but took many casualties.

Indeed, Uruguay, the first country in the world to declare that it would allow recreational reform, was blackmailed by the U.S. banking system for years after 2013 to slow down its internal development of the industry.

These days, that conversation is clearly not taking place, although federal reform (of any sort, let alone of the recreational kind) again seems to be destined to stall in the U.S. Congress.

Argentina certainly seems to be positioning itself on this issue as developments occur in both the U.S. and Germany (for starters). That makes a great deal of sense. Both countries are ideal export markets for a product that Argentina is well developed to deliver as a high value export crop in both hemispheres.

The post Argentina Makes Medical Cannabis Reform a National Priority appeared first on High Times.

Argentina Authorizes Nonprofit Patient Cannabis Collectives

While it may sound “old hat” to cannabis industry experts in North America, the government of Argentina has just made a bold move that will allow patients to access medical cannabis in a way not seen in most reforming jurisdictions elsewhere. Namely, the Argentine Ministry of Health has authorized specially licensed and permitted nonprofits to grow cannabis for medical patients.

Each NGO will be allowed to provide cannabis to up to 150 people, cultivate both in and outdoors and register multiple properties for the purpose of the same. Patients will also have to participate in a special registry called the Registry of the Cannabis Program (REPROCANN). Nonprofits who register more than 150 patients will also be allowed to request authorization for the extension of these patient counts to the National Program for the study and research of medicinal cannabis.

Resolution 673 modifies an Argentinian resolution passed in March of last year which established and regulated the operation of the REPROCANN program and created the basic parameters of controlled cultivation for medical users. 

The Details

Each nonprofit may cultivate up to nine plants per patient and will be allowed up to 6m2 for indoor cultivation and up to 15m2 for outdoor cultivation for this purpose. When transported by vehicle, up to six bottles of 30ml of cannabis extract or up to 40 grams of dried flowers will be allowed by authorized persons.

The program has been set up to simplify the guaranteed access to treatments for medical cannabis users and allow third parties to provide the same for registered patients.

Cannabis Reform in Argentina

Cannabis has been decriminalized in Argentina for personal use since the Supreme Court ruled on the same in 2009 and further decided that personal use was a constitutional right. Public consumption is generally tolerated. Consumption for medical purposes had not been regulated until now. Cultivation, selling and transporting cannabis however, remained illegal.

In March 2017, the Argentine Senate approved the medical use of CBD oil. In late November 2020, President Alberto Fernandez signed a decree allowing the self-cultivation of cannabis and subsidized medical access.

What Argentina is Getting Right

While hardly the most prominent cannabis reform program globally, it appears that the Argentine government is taking a page out of other reform programs that have been implemented elsewhere—as well as what has not worked.

For example, in both the US and Canada, patient collectives similar to those in Argentina became the basis of the legalizing commercial industry. However, in places like Holland, certainly until the formal national cultivation trial kicks in next year, and currently in Spain, the growth and cultivation of crops for coffeeshops and clubs remains largely unregulated. Transport between the cultivation site and the consumption and sales location remains a hazardous affair as the entire process is still in a gray area.

Beyond this, the idea of formalizing patient collectives has not caught on in places like Europe. At present, only Switzerland has plans to implement cannabis clubs that are federally regulated—although the first dispensation of the same will still occur in pharmacies.

The entire discussion of patient collectives and nonprofits is completely off the table in Germany, now in the process of establishing guidelines for recreational use (and unbelievably delaying the decriminalization process). Patients are still largely left to fend for themselves in a maze of bureaucratic red tape that starts with the reluctance of doctors to prescribe cannabis extracts and medicines (and even more so cannabis flower) and the repeated stymieing of these requests by insurance companies and the state-run regulator which makes the final approvals. 

When they do not get this, many patients (who do not suddenly stop being sick) turn to the black market, which is dangerous for patients on both the quality side and of course, facing criminal sanctions if they are caught with more than about five to 15 grams of weed (depending on where they are caught).

The post Argentina Authorizes Nonprofit Patient Cannabis Collectives appeared first on High Times.